Gene · 9760
Papers2,030
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 2,030
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| High-sensitive spatially resolved T cell receptor sequencing with SPTCR-seq. | Nat Commun | 2023 | 37973846 | PubTator, text mining | PubMed |
| Single-cell CRISPR screens in vivo map T cell fate regulomes in cancer. | Nature | 2023 | 37968405 | PubTator, text mining | PubMed |
| Single cell transcriptomics shows that malaria promotes unique regulatory responses across multiple immune cell subsets. | Nat Commun | 2023 | 37968278 | PubTator, text mining | PubMed |
| Single cell dynamics of tumor specificity vs bystander activity in CD8+ T cells define the diverse immune landscapes in colorectal cancer. | Cell Discov | 2023 | 37968259 | PubTator, text mining | PubMed |
| Salvage therapy expands highly cytotoxic and metabolically fit resilient CD8+ T cells via ME1 up-regulation. | Sci Adv | 2023 | 37967193 | PubTator, text mining | PubMed |
| Notch-based gene signature for predicting the response to neoadjuvant chemotherapy in triple-negative breast cancer. | J Transl Med | 2023 | 37964363 | PubTator, text mining | PubMed |
| Evaluation of mRNA Expressions of TOX and NR4As in CD8+ T cells in Acute Leukemia. | Iran J Immunol | 2023 | 37961948 | PubTator, text mining | PubMed |
| Machine learning links T cell function and spatial localization to neoadjuvant immunotherapy and clinical outcome in pancreatic cancer. | bioRxiv | 2023 | 37961410 | PubTator, text mining | PubMed |
| Comprehensive single cell aging atlas of mammary tissues reveals shared epigenomic and transcriptomic signatures of aging and cancer. | bioRxiv | 2023 | 37961129 | PubTator, text mining | PubMed |
| Whole-Exome Sequencing of 21 Families: Candidate Genes for Early-Onset High Myopia. | Int J Mol Sci | 2023 | 37958660 | PubTator, text mining | PubMed |
| Prognostic Markers within the Tumour Microenvironment in Classical Hodgkin Lymphoma. | Cancers (Basel) | 2023 | 37958391 | PubTator, text mining | PubMed |
| Abnormal low expression of SFTPC promotes the proliferation of lung adenocarcinoma by enhancing PI3K/AKT/mTOR signaling transduction. | Aging (Albany NY) | 2023 | 37955668 | PubTator, text mining | PubMed |
| Insights gained from single-cell analysis of chimeric antigen receptor T-cell immunotherapy in cancer. | Mil Med Res | 2023 | 37941075 | PubTator, text mining | PubMed |
| Epigenome-wide methylation and progression to high-grade cervical intraepithelial neoplasia (CIN2+): a prospective cohort study in the United States. | BMC Cancer | 2023 | 37932662 | PubTator, text mining | PubMed |
| Harnessing CD3 diversity to optimize CAR T cells. | Nat Immunol | 2023 | 37932456 | PubTator, text mining | PubMed |
| Combinatorial blockade for cancer immunotherapy: targeting emerging immune checkpoint receptors. | Front Immunol | 2023 | 37928556 | PubTator, text mining | PubMed |
| Remodeling the tumor immune microenvironment via siRNA therapy for precision cancer treatment. | Asian J Pharm Sci | 2023 | 37920650 | PubTator, text mining | PubMed |
| Hepatitis B surface antigen reduction is associated with hepatitis B core-specific CD8+ T cell quality. | Front Immunol | 2023 | 37920475 | PubTator, text mining | PubMed |
| Outbreak of Corynebacterium diphtheriae among asylum seekers in Belgium in 2022: operational challenges and lessons learnt. | Euro Surveill | 2023 | 37917029 | PubTator, text mining | PubMed |
| Single-cell characterization of macrophages in uveal melanoma uncovers transcriptionally heterogeneous subsets conferring poor prognosis and aggressive behavior. | Exp Mol Med | 2023 | 37907747 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9760/papers?page=17